VRNA

Verona Pharma
VRNA

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$8.40B
EV
$8.25B
Shares Outstanding
94.58M
Beta
0.22

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$97.10
P/E 2025E
179.38x
P/Revenue 2025E
20.00x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Verona Pharma plc

gainify
VRNA

Verona Pharma plc

VRNA

Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company’s product candidate is ensifentrine, an inhaled and dual inhibitor ...

Sector

Healthcare

Industry

Biotechnology

CEO

Zaccardelli, David

Employees

209

IPO Date

2017-04-28

Headquarters

3 More London Riverside, London, Greater London, SE1 2RE, United Kingdom

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.